Development of prediction model for alanine transaminase elevations during the first 6 months of conventional synthetic DMARD treatment.
Saved in:
| Title: | Development of prediction model for alanine transaminase elevations during the first 6 months of conventional synthetic DMARD treatment. |
|---|---|
| Authors: | Kuusalo L; Division of Medicine, Centre for Rheumatology and Clinical Immunology, University of Turku and Turku University Hospital, Kiinamyllynkatu 4-6, P.O. Box 52, 20521, Turku, Finland. laura.kuusalo@utu.fi., Venäläinen MS; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Tykistökatu 6, 20520, Turku, Finland.; Department of Medical Physics, Turku University Hospital, Turku, Finland., Kirjala H; Division of Medicine, Centre for Rheumatology and Clinical Immunology, University of Turku and Turku University Hospital, Kiinamyllynkatu 4-6, P.O. Box 52, 20521, Turku, Finland., Saranpää S; Division of Medicine, Centre for Rheumatology and Clinical Immunology, University of Turku and Turku University Hospital, Kiinamyllynkatu 4-6, P.O. Box 52, 20521, Turku, Finland., Elo LL; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Tykistökatu 6, 20520, Turku, Finland.; Institute of Biomedicine, University of Turku, Turku, Finland.; InFLAMES Research Flagship Center, University of Turku, Turku, Finland., Pirilä L; Division of Medicine, Centre for Rheumatology and Clinical Immunology, University of Turku and Turku University Hospital, Kiinamyllynkatu 4-6, P.O. Box 52, 20521, Turku, Finland. |
| Source: | Scientific reports [Sci Rep] 2023 Aug 09; Vol. 13 (1), pp. 12943. Date of Electronic Publication: 2023 Aug 09. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37558753 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Development of prediction model for alanine transaminase elevations during the first 6 months of conventional synthetic DMARD treatment. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kuusalo+L%22">Kuusalo L</searchLink>; Division of Medicine, Centre for Rheumatology and Clinical Immunology, University of Turku and Turku University Hospital, Kiinamyllynkatu 4-6, P.O. Box 52, 20521, Turku, Finland. laura.kuusalo@utu.fi.<br /><searchLink fieldCode="AU" term="%22Venäläinen+MS%22">Venäläinen MS</searchLink>; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Tykistökatu 6, 20520, Turku, Finland.; Department of Medical Physics, Turku University Hospital, Turku, Finland.<br /><searchLink fieldCode="AU" term="%22Kirjala+H%22">Kirjala H</searchLink>; Division of Medicine, Centre for Rheumatology and Clinical Immunology, University of Turku and Turku University Hospital, Kiinamyllynkatu 4-6, P.O. Box 52, 20521, Turku, Finland.<br /><searchLink fieldCode="AU" term="%22Saranpää+S%22">Saranpää S</searchLink>; Division of Medicine, Centre for Rheumatology and Clinical Immunology, University of Turku and Turku University Hospital, Kiinamyllynkatu 4-6, P.O. Box 52, 20521, Turku, Finland.<br /><searchLink fieldCode="AU" term="%22Elo+LL%22">Elo LL</searchLink>; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Tykistökatu 6, 20520, Turku, Finland.; Institute of Biomedicine, University of Turku, Turku, Finland.; InFLAMES Research Flagship Center, University of Turku, Turku, Finland.<br /><searchLink fieldCode="AU" term="%22Pirilä+L%22">Pirilä L</searchLink>; Division of Medicine, Centre for Rheumatology and Clinical Immunology, University of Turku and Turku University Hospital, Kiinamyllynkatu 4-6, P.O. Box 52, 20521, Turku, Finland. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101563288%22">Scientific reports</searchLink> [Sci Rep] 2023 Aug 09; Vol. 13 (1), pp. 12943. <i>Date of Electronic Publication: </i>2023 Aug 09. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101563288 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2045-2322 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220452322%22">20452322 </searchLink><i>NLM ISO Abbreviation: </i>Sci Rep <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37558753 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41598-023-39694-2 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 12943 Titles: – TitleFull: Development of prediction model for alanine transaminase elevations during the first 6 months of conventional synthetic DMARD treatment. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kuusalo L – PersonEntity: Name: NameFull: Venäläinen MS – PersonEntity: Name: NameFull: Kirjala H – PersonEntity: Name: NameFull: Saranpää S – PersonEntity: Name: NameFull: Elo LL – PersonEntity: Name: NameFull: Pirilä L IsPartOfRelationships: – BibEntity: Dates: – D: 09 M: 08 Text: 2023 Aug 09 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 2045-2322 Numbering: – Type: volume Value: 13 – Type: issue Value: 1 Titles: – TitleFull: Scientific reports Type: main |
| ResultId | 1 |
